[Clinico-immunologic aspects of using mildronate in patients with bronchopulmonary diseases].
The immunity status of 35 patients with chronic bronchitis and infectious and allergic bronchial asthma was studied. Defects in the humoral immunity were revealed. To correct the immunity status, all the patients were treated with mildronate. The immunomodulatory effect of mildronate was found in all the groups of the patients. Mildronate was shown to increase the activity of a secondary immune response and the bronchial potency in the persons with infectious and allergic asthma.
Orlov
V A
VA
Sokolova
V I
VI
Zamotaev
I P
IP
Elagina
L V
LV
Zavolovskaia
L I
LI
D000276:Adjuvants, Immunologic; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D001980:Bronchi / Q000187:drug effects* / Q000276:immunology; D001991:Bronchitis / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D001993:Bronchodilator Agents; D002908:Chronic Disease; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy* / Q000276:immunology; D007108:Immune Tolerance / Q000187:drug effects* / Q000276:immunology; D008763:Methylhydrazines / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D001993:Bronchodilator Agents; D008763:Methylhydrazines; C050147:3-(2,2,2-trimethylhydrazine)propionate
Kliniko-immunologicheskie aspekty primeneniia mildronata u bol'nykh s bronkholegochnymi zabolevaniiami.